Concepedia
Statistics
Publications
6
Citations
246
H-Index
Active since
2011
Affiliations
Inserm(Current)
University Hospital of Geneva
Institut des Cellules Souches pour le Traitement et l'Étude des Maladies Monogéniques
University of Geneva
Rémi Vernet is an author at Inserm specializing in life sciences, cell therapy, and immunotherapy for solid tumors.
Publications per year
2011–2022
Mutant Human Embryonic Stem Cells Reveal Neurite and Synapse Formation Defects in Type 1 Myotonic Dystrophy
Antoine Marteyn, Yves Maury, Morgane Gauthier et al. · Cell stem cell · 2011 · 108 citations · Full text
Life Sciences, Cell Biology, Neuroscience +16
First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapies
Denis Migliorini, Nicolas Mach, Diego Aguiar et al. · OncoImmunology · 2017 · 76 citations · Full text
Medicine, Immunology, Oncology +12
Integration-deficient lentivectors: an effective strategy to purify and differentiate human embryonic stem cell-derived hepatic progenitors
Guanghua Yang, Karim Si‐Tayeb, Sébastien Corbineau et al. · BMC Biology · 2013 · 22 citations · Full text
Life Sciences, Biotechnology, Developmental Biology +17
A defective Krab-domain zinc-finger transcription factor contributes to altered myogenesis in myotonic dystrophy type 1
Morgane Gauthier, Antoine Marteyn, Jérôme Alexandre Denis et al. · Human Molecular Genetics · 2013 · 15 citations · Full text
Life Sciences, Genetics, Molecular Genetics +15
MVX-ONCO-1 phase 1 final results of the first personalized cell-based immunotherapy using cell encapsulation technology
Nicolas Mach, Rémi Vernet, Marie‐Claude Belkouch et al. · Annals of Oncology · 2016 · 13 citations
Pharmacy, Immunology, Oncology +17
1–5 of 6